Malaria and hypertension. Another co-evolutionary adaptation?

Frontiers in Cellular and Infection Microbiology

Volumn 4, Issue SEP, 2014, Pages

  Gallego Delgado, Julio ^a   Rodriguez, Ana ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Ethnicity; Evolutionary adaptation; Hypertension; Malaria; Plasmodium; Polymorphism

Indexed keywords

CAPTOPRIL; LOSARTAN;

ARTICLE; BLOOD PRESSURE MONITORING; DNA POLYMORPHISM; HUMAN; HYPERTENSION; HYPONATREMIA; INFLAMMATION; MALARIA; MALARIA FALCIPARUM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; COMPLICATION; EVOLUTION;

BIOLOGICAL EVOLUTION; HUMANS; HYPERTENSION; MALARIA;

EID: 84907056792     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2014.00121     Document Type: Article

References (47)

1. Addo, J., Smeeth, L., and Leon, D. A. (2007). Hypertension in sub-saharan Africa: a systematic review. Hypertension 50, 1012-1018. doi: 10.1161/HYPERTENSIONAHA.107.093336
2. Alrajhi, A. A., Rahim, I., Akood, M., and Hazmi, M. (1999). Chloroquine-resistant Plasmodium falciparum cerebral malaria in a chloroquine-susceptible area. J. Infect. Dis. 180, 1738-1741. doi: 10.1086/315083
3. Amani, V., Boubou, M. I., Pied, S., Marussig, M., Walliker, D., Mazier, D., et al. (1998). Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect. Immun. 66, 4093-4099.
4. Bader, M. (2010). Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Annu. Rev. Pharmacol. Toxicol. 50, 439-465. doi: 10.1146/annurev.pharmtox.010909.105610
5. Bejon, P., Andrews, L., Andersen, R. F., Dunachie, S., Webster, D., Walther, M., et al. (2005). Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. J. Infect. Dis. 191, 619-626. doi: 10.1086/427243
6. Benigni, A., Cassis, P., and Remuzzi, G. (2010). Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol. Med. 2, 247-257. doi: 10.1002/emmm.201000080
7. Callera, G., Tostes, R., Savoia, C., Muscara, M. N., and Touyz, R. M. (2007). Vasoactive peptides in cardiovascular (patho)physiology. Expert Rev. Cardiovasc. Ther. 5, 531-552. doi: 10.1586/14779072.5.3.531
8. Cappuccio, F. P. (1997). Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J. Hum. Hypertens. 11, 571-576.
9. de Gasparo, M., Whitebread, S., Mele, M., Motani, A. S., Whitcombe, P. J., Ramjoue, H. P., et al. (1990). Biochemical characterization of two angiotensin II receptor subtypes in the rat. J. Cardiovasc. Pharmacol. (16 Suppl. 4), S31-S35.
10. Delahaye, N. F., Coltel, N., Puthier, D., Barbier, M., Benech, P., Joly, F., et al. (2007). Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice. BMC Genomics 8:452. doi: 10.1186/1471-2164-8-452
11. Dhangadamajhi, G., Mohapatra, B. N., Kar, S. K., and Ranjit, M. (2009). Endothelial nitric oxide synthase gene polymorphisms and Plasmodium falciparum infection in Indian adults. Infect. Immun. 77, 2943-2947. doi: 10.1128/IAI.00083-09
12. Dhangadamajhi, G., Mohapatra, B. N., Kar, S. K., and Ranjit, M. (2010). Gene polymorphisms in angiotensin I converting enzyme (ACE I/D) and angiotensin II converting enzyme (ACE2 C->T) protect against cerebral malaria in Indian adults. Infect. Genet. Evol. 10, 337-341. doi: 10.1016/j.meegid.2010.01.009
13. Di Pasquale, P., Cannizzaro, S., and Paterna, S. (2004). Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects. Eur. J. Heart Fail. 6, 11-16. doi: 10.1016/j.ejheart.2003.07.009
14. Falcon, B. L., Veerasingham, S. J., Sumners, C., and Raizada, M. K. (2005). Angiotensin II type 2 receptor-mediated gene expression profiling in human coronary artery endothelial cells. Hypertension 45, 692-697. doi: 10.1161/01.HYP.0000154254.89733.29
15. Fan, X., Wang, Y., Sun, K., Zhang, W., Yang, X., Wang, S., et al. (2007). Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women. Clin. Pharmacol. Ther. 82, 187-196. doi: 10.1038/sj.clpt.6100214
16. Gallego-Delgado, J. T. M., Alique, M., Wassmer, S., Ruiz-Ortega, M., and Rodriguez, A. (eds.). (2013). "Abstract book," in ASTMH 62nd Annual Meeting (Washington, DC: The American Journal of Tropical Medicine and Hygiene).
17. Giner, V., Poch, E., Bragulat, E., Oriola, J., Gonzalez, D., Coca, A., et al. (2000). Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension 35(1 Pt 2), 512-517. doi: 10.1161/01.HYP.35.1.512
18. Gramaglia, I., Sobolewski, P., Meays, D., Contreras, R., Nolan, J. P., Frangos, J. A., et al. (2006). Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat. Med. 12, 1417-1422. doi: 10.1038/nm1499
19. Gupta, A. K. (2010). Racial differences in response to antihypertensive therapy: does one size fits all? Int. J. Prev. Med. 1, 217-219.
20. Gupta, A. K., Poulter, N. R., Dobson, J., Eldridge, S., Cappuccio, F. P., Caulfield, M., et al. (2010). Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial. Am. J. Hypertens. 23, 1023-1030. doi: 10.1038/ajh.2010.105
21. Habashi, J. P., Doyle, J. J., Holm, T. M., Aziz, H., Schoenhoff, F., Bedja, D., et al. (2011). Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332, 361-365. doi: 10.1126/science.1192152
22. Hanson, J., Hossain, A., Charunwatthana, P., Hassan, M. U., Davis, T. M., Lam, S. W., et al. (2009). Hyponatremia in severe malaria: evidence for an appropriate anti-diuretic hormone response to hypovolemia. Am. J. Trop. Med. Hyg. 80, 141-145.
23. Idro, R., Jenkins, N. E., and Newton, C. R. (2005). Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 4, 827-840. doi: 10.1016/S1474-4422(05)70247-7
24. Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., et al. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224-2260. doi: 10.1016/S0140-6736(12)61766-8
25. Lloyd-Sherlock, P., Ebrahim, S., and Grosskurth, H. (2014). Is hypertension the new HIV epidemic? Int. J. Epidemiol. 43, 8-10. doi: 10.1093/ije/dyu019
26. Maciel, C., de Oliveira Junior, V. X., Fazio, M. A., Nacif-Pimenta, R., Miranda, A., Pimenta, P. F., et al. (2008). Anti-plasmodium activity of angiotensin II and related synthetic peptides. PLoS ONE 3:e3296. doi: 10.1371/journal.pone.0003296
27. Marchesi, C., Paradis, P., and Schiffrin, E. L. (2008). Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol. Sci. 29, 367-374. doi: 10.1016/j.tips.2008.05.003
28. McCarthy, C. A., Vinh, A., Callaway, J. K., and Widdop, R. E. (2009). Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 40, 1482-1489. doi: 10.1161/STROKEAHA.108.531509
29. Miller, L. H., Ackerman, H. C., Su, X. Z., and Wellems, T. E. (2013). Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19, 156-167. doi: 10.1038/nm.3073
30. Mokwe, E., Ohmit, S. E., Nasser, S. A., Shafi, T., Saunders, E., Crook, E., et al. (2004). Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension 43, 1202-1207. doi: 10.1161/01.HYP.0000127924.67353.86
31. Newbold, C., Warn, P., Black, G., Berendt, A., Craig, A., Snow, B., et al. (1997). Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 57, 389-398.
32. Peck, R. N., Smart, L. R., Beier, R., Liwa, A. C., Grosskurth, H., Fitzgerald, D. W., et al. (2013). Difference in blood pressure response to ACE-Inhibitor monotherapy between black and white adults with arterial hypertension: a meta-analysis of 13 clinical trials. BMC Nephrol. 14:201. doi: 10.1186/1471-2369-14-201
33. Phillips, A., Bassett, P., Zeki, S., Newman, S., and Pasvol, G. (2009). Risk factors for severe disease in adults with falciparum malaria. Clin. Infect. Dis. 48, 871-878. doi: 10.1086/597258
34. Rasti, N., Wahlgren, M., and Chen, Q. (2004). Molecular aspects of malaria pathogenesis. FEMS Immunol. Med. Microbiol. 41, 9-26. doi: 10.1016/j.femsim.2004.01.010
35. Roze, E., Thiebaut, M. M., Mazevet, D., Bricaire, F., Danis, M., Deseilligny, C. P., et al. (2001). Neurologic sequelae after severe falciparum malaria in adult travelers. Eur. Neurol. 46, 192-197. doi: 10.1159/000050803
36. Sampson, U. K., Edwards, T. L., Jahangir, E., Munro, H., Wariboko, M., Wassef, M. G., et al. (2014). Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study. Circ. Cardiovasc. Qual. Outcomes 7, 33-54. doi: 10.1161/CIRCOUTCOMES.113.000155
37. Saraiva, V. B., de Souza Silva, L., Ferreira-DaSilva, C. T., da Silva-Filho, J. L., Teixeira-Ferreira, A., Perales, J., et al. (2011). Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides. PLoS ONE 6:e17174. doi: 10.1371/journal.pone.0017174
38. Silva-Filho, J. L., Souza, M. C., Ferreira-Dasilva, C. T., Silva, L. S., Costa, M. F., Padua, T. A., et al. (2013). Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection. PLoS ONE 8:e62999. doi: 10.1371/journal.pone.0062999
39. Tanabe, K., Mita, T., Jombart, T., Eriksson, A., Horibe, S., Palacpac, N., et al. (2010). Plasmodium falciparum accompanied the human expansion out of Africa. Curr. Biol. 20, 1283-1289. doi: 10.1016/j.cub.2010.05.053
40. Touyz, R. M., and Schiffrin, E. L. (2000). Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 52, 639-672.
41. Turner, L., Lavstsen, T., Berger, S. S., Wang, C. W., Petersen, J. E., Avril, M., et al. (2013). Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 498, 502-205. doi: 10.1038/nature12216
42. van Wolfswinkel, M. E., Hesselink, D. A., Zietse, R., Hoorn, E. J., and van Genderen, P. J. (2010). Hyponatraemia in imported malaria is common and associated with disease severity. Malar. J. 9, 140. doi: 10.1186/1475-2875-9-140
43. Wolz, M., Cutler, J., Roccella, E. J., Rohde, F., Thom, T., and Burt, V. (2000). Statement from the National High Blood Pressure Education Program: prevalence of hypertension. Am. J. Hypertens. 13(1 Pt 1), 103-104. doi: 10.1016/S0895-7061(99)00241-1
44. World Health Organization. (2012a). World Malaria Report 2012. Vol. xxxiv. Geneva: World Health Organization.
45. World Health Organization. (2012b). International Travel and Health: Situation as on 1 January 2012. Vol. xi. Geneva: World Health Organization.
46. World Health Organization. (2013). A Global Brief on Hypertension. Geneva: World Health Organization. Available online at: http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/
47. Yayama, K., and Okamoto, H. (2008). Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide. Int. Immunopharmacol. 8, 312-318. doi: 10.1016/j.intimp.2007.06.012